Food noise is background chatter
The central objectives are to disrupt cancer cell metabolic plasticity, prevent interconversion between distinct metabolic states, and concurrently reprogram the immunometabolic landscape to restore therapeutic sensitivity [127]
Novikoff A, OBrien SL, Bernecker M, et al
But dont worry, thats where we come in
In Big Pharma, Eli Lilly announced Phase 3 results of an oral GLP-1 RA and Pfizer expands its GLP-1 portfolio by acquiring Metsera
In this study, PBAT-MPs induced marked dysbiosis characterized by depletion of Muribaculaceae and Alloprevotella two key SCFA-associated taxatogether with expansion of Gram-negative opportunistic pathogens, including Escherichia Shigella and Acinetobacter